101 related articles for article (PubMed ID: 1361111)
1. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms.
Hanson GR; Singh N; Merchant K; Johnson M; Bush L; Gibb JW
Ann N Y Acad Sci; 1992; 668():165-72. PubMed ID: 1361111
[TBL] [Abstract][Full Text] [Related]
2. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
Singh NA; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
[TBL] [Abstract][Full Text] [Related]
4. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment.
Hanson GR; Midgley LP; Bush LG; Gibb JW
Eur J Pharmacol; 1995 May; 278(2):167-73. PubMed ID: 7672001
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
6. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
[TBL] [Abstract][Full Text] [Related]
7. The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse.
Hanson GR; Singh N; Merchant K; Johnson M; Gibb JW
Drug Alcohol Depend; 1995 Feb; 37(2):107-10. PubMed ID: 7758400
[TBL] [Abstract][Full Text] [Related]
8. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
Westwood SC; Hanson GR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
[TBL] [Abstract][Full Text] [Related]
9. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.
Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR
Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999
[TBL] [Abstract][Full Text] [Related]
10. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
Alburges ME; Hanson GR
Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
[TBL] [Abstract][Full Text] [Related]
11. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
[TBL] [Abstract][Full Text] [Related]
12. Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
Brain Res; 1997 Feb; 748(1-2):241-4. PubMed ID: 9067469
[TBL] [Abstract][Full Text] [Related]
13. Mephedrone alters basal ganglia and limbic neurotensin systems.
German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
15. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
16. Response of limbic neurotensin systems to methamphetamine self-administration.
Hanson GR; Hoonakker AJ; Alburges ME; McFadden LM; Robson CM; Frankel PS
Neuroscience; 2012 Feb; 203():99-107. PubMed ID: 22245499
[TBL] [Abstract][Full Text] [Related]
17. Striatal dopamine receptor plasticity in neurotensin deficient mice.
Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems.
Johnson M; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1991 Feb; 193(3):367-70. PubMed ID: 1675997
[TBL] [Abstract][Full Text] [Related]
19. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
20. Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity.
Wagstaff JD; Bush LG; Gibb JW; Hanson GR
Brain Res; 1994 Dec; 665(2):237-44. PubMed ID: 7895059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
